HER2 protein overexpression in non ‐amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?

This study compares HER2 immunohistochemistry (IHC) and chromogenicin situ hybridization (CISH) between admixed synchronous in situ and invasive carcinomas exhibiting an equivocal 2+ HER2 IHC score in the invasive component.This article is protected by copyright. All rights reserved.

Source: Histopathology - November 27, 2018 Category: Pathology Authors: Kathleen Lambein, Louis Libbrecht, Christine Galant, Mieke R. Van Bockstal Tags: Correspondence Source Type: research